ArticleNature communications2026
Dynamic palladium catalysis enables chiral amplification toward acyclic Schiff base atropisomers.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Schiff bases, despite their structural versatility and broad applications, have remained elusive as acyclic atropisomers due to synthetic challenges. Herein, we report a palladium-catalyzed asymmetric N-allylation of diarylmethanimines with allylic precursors, enabling the construction of acyclic Schiff base atropisomers bearing C-C axes. Crucially, dynamic ligand exchange between the imine substrates and the palladium pre-catalyst drives its evolution from a less active to a more reactive species. This self-optimizing system leads to a unique time-dependent enhancement of enantioselectivity up to 96% ee. Experimental and density functional theory studies reveal that substrate-induced reorganization of the catalytic system optimizes the reaction pathway, leading to high yields (up to 83%) and absolute Z stereoselectivity. The method exhibits remarkable functional group tolerance and scalability, and its utility is demonstrated through diverse transformations. This work provides efficient access to previously inaccessible atropisomeric scaffolds and establishes a paradigm of substrate-guided catalyst evolution for asymmetric catalysis.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.